Science & Technology
Science and Technology
Science and Technology
Mon, July 19, 2010
Sat, July 17, 2010
Fri, July 16, 2010
Thu, July 15, 2010
Zacks Releases Four Powerful ''Buy'' Stocks: Novellus Systems, Analog Devices, VeriFone Systems and China-Biotics
CHICAGO--([ BUSINESS WIRE ])--Four free stock picks are being made available today on Zacks.com. The industrya™s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.
"earnings estimate revisions are the most powerful force impacting stock prices."
The four highlighted picks are: Novellus Systems (Nasdaq: [ NVLS ]), Analog Devices (NYSE: [ ADI ]), VeriFone Systems, Inc. (NYSE: [ PAY ]) and China-Biotics, Inc. (Nasdaq: [ CHBT ]).
Today, Zacks is promoting its ''Buy'' stock recommendations. Four daily picks are offered free at [ http://at.zacks.com/?id=88 ].
Zacks #1 Rank Stocks have nearly tripled the S&P 500 since 1988, producing an average annual return of +26%. Performance has been notable even during volatile and down times. For example, during the last bear market, 2000-2002, the market tumbled -37.6% a" but Zacks #1 Rank stocks gained +43.8%.
Here is a summary of today's selected stocks that are now highly rated by Zacks:
Aggressive Growth a" [ Novellus Systems ](Nasdaq: [ NVLS ])
Novellus Systems analysts continue to raise estimates as demand increases. The company also just topped expectations for the fourth consecutive quarter.
Zacks Guide to Aggressive Growth Investing (free!): [ http://at.zacks.com/?id=4309 ]
Growth & Income a" [ Analog Devices ](NYSE: [ ADI ])
Analog Devices is a cheap tech stock with solid growth prospects and a decent dividend yield.
Zacks Guide to Growth & Income Investing (free!): [ http://at.zacks.com/?id=4310 ]
Momentum a" [ VeriFone Systems, Inc. ] (NYSE: [ PAY ])
VeriFone Systems, Inc. continues to trade within $2 of its multi-year high on a solid 9% earnings surprise from late May. With an average earnings surprise of 27% over the last four quarters and rising estimates, this Zacks #1 rank stocks has some solid upward momentum.
Zacks Guide to Momentum Investing (free!): [ http://at.zacks.com/?id=4311 ]
Value a" [ China-Biotics, Inc. ] (Nasdaq: [ CHBT ])
China-Biotics, Inc. recently reported record full year revenue but the stock is still cheap, trading at just 7.6x forward earnings compared to its industry which trades at 13.6.
Zacks Guide to Value Investing (free!): [ http://at.zacks.com/?id=4312 ]
How to Regularly Access Top Zacks Rank Picks for Free:[ http://at.zacks.com/?id=7154 ]
Underlying the four free stock picks is a simple truth that first appeared in a Financial Analysts Journal article published in 1979. Leonard Zacks, a Ph.D. in Mathematics from M.I.T. found that "earnings estimate revisions are the most powerful force impacting stock prices." Zacks #1 Rank is awarded to a stock when analysts sharply upgrade their estimates of what the company will earn.
Today, Zacks is promoting its stock recommendations by offering four daily picks free to those who register at [ http://at.zacks.com/?id=7155 ].
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms. It monitors more than 200,000 earnings estimates, looking for changes.
Then, when changes are discovered, theya™re applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.
More Free Stock Picks
Each weekday, new Zacks #1 Rank or Zacks #2 Rank stock picks are released on the free email newsletter, Profit from the Pros. Investors are invited to register for their free subscription at [ http://at.zacks.com/?id=91 ].
Follow us on Twitter: [ http://twitter.com/zacksresearch ]
Join us on Facebook: [ http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts ]
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Visit [ http://www.zacks.com/performance ] for information about the performance numbers displayed in this press release.
